Albert Lo

4.9k total citations · 3 hit papers
18 papers, 2.8k citations indexed

About

Albert Lo is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Albert Lo has authored 18 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Albert Lo's work include CAR-T cell therapy research (6 papers), Peptidase Inhibition and Analysis (5 papers) and Immune Cell Function and Interaction (5 papers). Albert Lo is often cited by papers focused on CAR-T cell therapy research (6 papers), Peptidase Inhibition and Analysis (5 papers) and Immune Cell Function and Interaction (5 papers). Albert Lo collaborates with scholars based in United States, Taiwan and Slovakia. Albert Lo's co-authors include Ellen Puré, Steven Μ. Albelda, Carl H. June, Kheng Newick, Edmund K. Moon, Liang‐Chuan S. Wang, Han‐Chung Wu, Amy C. Durham, John Scholler and Jing Sun and has published in prestigious journals such as Science, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Albert Lo

18 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

2016 420 citations Xiaojun Liu, Raghuveer Ranganathan et al. Cancer Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →

Peers

Countries citing papers authored by Albert Lo

Since Specialization

Citations

This map shows the geographic impact of Albert Lo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Lo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Lo more than expected).

Fields of papers citing papers by Albert Lo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Lo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Lo. The network helps show where Albert Lo may publish in the future.

Co-authorship network of co-authors of Albert Lo

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Lo. A scholar is included among the top collaborators of Albert Lo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Lo. Albert Lo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	CRISPR-mediated live imaging of genome editing and transcription 2019 ·Science ·Haifeng Wang, Muneaki Nakamura, Timothy R. Abbott, Dehua Zhao, (unknown), (unknown), Cindy M. Nguyen, Albert Lo, Timothy Daley, Marie La Russa, Yanxia Liu, Lei S. Qi	219
2	Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma 2017 ·JCI Insight ·Albert Lo, Chung‐Pin Li, Elizabeth L. Buza, Rachel Blomberg, Priya Govindaraju, Diana Avery, James Monslow, Michael Hsiao, Ellen Puré	114
3	Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines 2017 ·OncoImmunology ·Edmund K. Moon, Liang‐Chuan S. Wang, (unknown), Rachel C. Lynn, Albert Lo, Stephen H. Thorne, Steven Μ. Albelda	140
4	A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors breakdown → 2016 ·Cancer Research ·Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H. June, Yangbing Zhao, Edmund K. Moon	420
5	Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization 2016 ·Cancer Immunology Research ·Kheng Newick, Shaun O’Brien, Jing Sun, Veena Kapoor, (unknown), Albert Lo, Ellen Puré, Edmund K. Moon, Steven Μ. Albelda	160
6	Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors? 2016 ·Cancer Immunology Research ·Ellen Puré, Albert Lo	89
7	Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors 2015 ·Cancer Immunology Research ·Enxiu Wang, Liang-Chuan Wang, Ching‐Yi Tsai, Vijay Bhoj, (unknown), Edmund K. Moon, Kheng Newick, Jing Sun, Albert Lo, Timothy Baradet, Michael D. Feldman, David M. Barrett, Ellen Puré, Steven Albelda, Michael C. Milone	91
8	Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer 2015 ·Clinical Cancer Research ·Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O’Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, Steven Μ. Albelda	96
9	Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells breakdown → 2015 ·Cancer Research ·Albert Lo, Liang‐Chuan S. Wang, John Scholler, James Monslow, Diana Avery, Kheng Newick, Shaun O’Brien, Rebecca A. Evans, David J. Bajor, Cynthia Clendenin, Amy C. Durham, Elizabeth L. Buza, Robert H. Vonderheide, Carl H. June, Steven Μ. Albelda, Ellen Puré	407
10	Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer 2015 ·American Journal Of Pathology ·Becky K. Brisson, Elizabeth A. Mauldin, Weiwei Lei, (unknown), (unknown), Albert Lo, (unknown), Chand Khanna, Rebecca G. Wells, Ellen Puré, Susan W. Volk	84
11	Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity breakdown → 2013 ·Cancer Immunology Research ·Liang‐Chuan S. Wang, Albert Lo, John Scholler, Jing Sun, R. Sonali Majumdar, Veena Kapoor, Michael Antzis, Cody E. Cotner, Laura A. Johnson, Amy C. Durham, Charalambos Solomides, Carl H. June, Ellen Puré, Steven Μ. Albelda	515
12	Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging 2013 ·PLoS ONE ·Ruei‐Min Lu, Minshan Chen, De-Kuan Chang, Chien‐Yu Chiu, (unknown), (unknown), Yi‐Ping Wang, (unknown), (unknown), Albert Lo, Han‐Chung Wu	73
13	Treatment of Aldosterone-Secreting Adrenocortical Tumors in Cats by Unilateral Adrenalectomy: 10 Cases (2002–2012) 2013 ·Journal of Veterinary Internal Medicine ·Albert Lo, David E. Holt, Dorothy Cimino Brown, (unknown), ROBERT J. ORSHER, Kimberly A. Agnello	22
14	Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer 2013 ·Human Pathology ·Julia Tchou, Paul J. Zhang, Yingtao Bi, (unknown), (unknown), Tom L. Stephen, Albert Lo, Haiying Chen, Carolyn Mies, Carl H. June, José R. Conejo-García, Ellen Puré	80
15	IL‐15 modulates the balance between Bcl‐2 and Bim via a Jak3/1‐PI3K‐Akt‐ERK pathway to promote CD8αα⁺ intestinal intraepithelial lymphocyte survival 2013 ·European Journal of Immunology ·Yein‐Gei Lai, (unknown), Albert Lo, (unknown), (unknown), Hsin‐Fang Yang‐Yen, Nan‐Shih Liao	24
16	Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors 2009 ·Journal of Biological Chemistry ·De-Kuan Chang, Chien‐Yu Chiu, (unknown), (unknown), Albert Lo, Yi‐Ping Wang, Pi‐Chun Li, Han‐Chung Wu	82
17	Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery 2008 ·Cancer Research ·Albert Lo, Chin‐Tarng Lin, Han‐Chung Wu	4
18	Hepatocellular carcinoma cell-specific peptide ligand for targeted drug delivery 2008 ·Molecular Cancer Therapeutics ·Albert Lo, Chin‐Tarng Lin, Han‐Chung Wu	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact